市場調査レポート
商品コード
1307933

インフルエンザ診断の世界市場 2023-2027

Global Influenza Diagnostics Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 170 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
インフルエンザ診断の世界市場 2023-2027
出版日: 2023年06月07日
発行: TechNavio
ページ情報: 英文 170 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インフルエンザ診断市場は2022-2027年に4億6,618万米ドル、予測期間中のCAGRは6.95%で成長すると予測されています。

当レポートでは、インフルエンザ診断市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、インフルエンザ罹患率の上昇、分子診断薬に対する需要の高まり、政府の支援策や資金援助によって牽引されています。

本調査では、今後数年間のインフルエンザ診断市場の成長を牽引する主な要因の一つとして、インフルエンザ診断薬の承認件数の増加を挙げています。また、インフルエンザウイルスの遺伝子解析研究の急増や、医師の研究室での迅速診断製品の採用が増加していることも、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2022
  • 市場の見通し 2022-2027

第4章 市場規模実績

  • インフルエンザ診断の世界市場 2023-2027 2017-2021
  • エンドユーザーセグメント分析 2017-2021
  • タイプセグメント分析 2017-2021
  • 地域別セグメント分析 2017-2021
  • 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 病院および診断研究所:市場規模と予測 2022-2027
  • 学術研究センター:市場規模と予測 2022-2027
  • ホームケア:市場規模と予測 2022-2027
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • ポイントオブケア検査:市場規模と予測 2022-2027
  • 免疫診断:市場規模と予測 2022-2027
  • 分子診断:市場規模と予測 2022-2027
  • 市場機会:タイプ別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2022-2027
  • 欧州:市場規模と予測 2022-2027
  • アジア:市場規模と予測 2022-2027
  • 世界のその他の地域:市場規模と予測 2022-2027
  • 米国:市場規模と予測 2022-2027
  • 中国:市場規模と予測 2022-2027
  • ドイツ:市場規模と予測 2022-2027
  • フランス:市場規模と予測 2022-2027
  • カナダ:市場規模と予測 2022-2027
  • 地域情勢別市場機会

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Becton Dickinson and Co.
  • BICO Group AB
  • Bio Rad Laboratories Inc.
  • Biocartis Group NV
  • bioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • Princeton BioMeditech Corp.
  • Quidelortho Corp.
  • Sd Biosensor Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Market opportunity by End-user ($ million)
  • Exhibits47: Data Table on Market opportunity by End-user ($ million)
  • Exhibits48: Chart on Type - Market share 2022-2027 (%)
  • Exhibits49: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits50: Chart on Comparison by Type
  • Exhibits51: Data Table on Comparison by Type
  • Exhibits52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibits58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibits62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibits64: Market opportunity by Type ($ million)
  • Exhibits65: Data Table on Market opportunity by Type ($ million)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on France - Market size and forecast 2022-2027 ($ million)
  • Exhibits100: Data Table on France - Market size and forecast 2022-2027 ($ million)
  • Exhibits101: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on France - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ million)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits109: Impact of drivers and challenges in 2022 and 2027
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: Abbott Laboratories - Overview
  • Exhibits116: Abbott Laboratories - Business segments
  • Exhibits117: Abbott Laboratories - Key news
  • Exhibits118: Abbott Laboratories - Key offerings
  • Exhibits119: Abbott Laboratories - Segment focus
  • Exhibits120: Becton Dickinson and Co. - Overview
  • Exhibits121: Becton Dickinson and Co. - Business segments
  • Exhibits122: Becton Dickinson and Co. - Key news
  • Exhibits123: Becton Dickinson and Co. - Key offerings
  • Exhibits124: Becton Dickinson and Co. - Segment focus
  • Exhibits125: BICO Group AB - Overview
  • Exhibits126: BICO Group AB - Business segments
  • Exhibits127: BICO Group AB - Key offerings
  • Exhibits128: BICO Group AB - Segment focus
  • Exhibits129: Bio Rad Laboratories Inc. - Overview
  • Exhibits130: Bio Rad Laboratories Inc. - Business segments
  • Exhibits131: Bio Rad Laboratories Inc. - Key news
  • Exhibits132: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits133: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits134: Biocartis Group NV - Overview
  • Exhibits135: Biocartis Group NV - Product / Service
  • Exhibits136: Biocartis Group NV - Key offerings
  • Exhibits137: bioMerieux SA - Overview
  • Exhibits138: bioMerieux SA - Product / Service
  • Exhibits139: bioMerieux SA - Key offerings
  • Exhibits140: Danaher Corp. - Overview
  • Exhibits141: Danaher Corp. - Business segments
  • Exhibits142: Danaher Corp. - Key news
  • Exhibits143: Danaher Corp. - Key offerings
  • Exhibits144: Danaher Corp. - Segment focus
  • Exhibits145: DiaSorin SpA - Overview
  • Exhibits146: DiaSorin SpA - Business segments
  • Exhibits147: DiaSorin SpA - Key news
  • Exhibits148: DiaSorin SpA - Key offerings
  • Exhibits149: DiaSorin SpA - Segment focus
  • Exhibits150: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits152: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits155: Hologic Inc. - Overview
  • Exhibits156: Hologic Inc. - Business segments
  • Exhibits157: Hologic Inc. - Key news
  • Exhibits158: Hologic Inc. - Key offerings
  • Exhibits159: Hologic Inc. - Segment focus
  • Exhibits160: Princeton BioMeditech Corp. - Overview
  • Exhibits161: Princeton BioMeditech Corp. - Product / Service
  • Exhibits162: Princeton BioMeditech Corp. - Key offerings
  • Exhibits163: Quidelortho Corp. - Overview
  • Exhibits164: Quidelortho Corp. - Product / Service
  • Exhibits165: Quidelortho Corp. - Key offerings
  • Exhibits166: Sd Biosensor Inc. - Overview
  • Exhibits167: Sd Biosensor Inc. - Product / Service
  • Exhibits168: Sd Biosensor Inc. - Key offerings
  • Exhibits169: Siemens Healthineers AG - Overview
  • Exhibits170: Siemens Healthineers AG - Business segments
  • Exhibits171: Siemens Healthineers AG - Key news
  • Exhibits172: Siemens Healthineers AG - Key offerings
  • Exhibits173: Siemens Healthineers AG - Segment focus
  • Exhibits174: Thermo Fisher Scientific Inc. - Overview
  • Exhibits175: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits176: Thermo Fisher Scientific Inc. - Key news
  • Exhibits177: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits178: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits179: Inclusions checklist
  • Exhibits180: Exclusions checklist
  • Exhibits181: Currency conversion rates for US$
  • Exhibits182: Research methodology
  • Exhibits183: Validation techniques employed for market sizing
  • Exhibits184: Information sources
  • Exhibits185: List of abbreviations
目次
Product Code: IRTNTR44375

The influenza diagnostics market is forecasted to grow by USD 466.18 mn during 2022-2027, accelerating at a CAGR of 6.95% during the forecast period. The report on the influenza diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of influenza, growing demand for molecular diagnostics, and supportive government initiatives and funding.

Technavio's influenza diagnostics market is segmented as below:

By End-user

  • Hospitals and diagnostic laboratories
  • Academic and research centers
  • Homecare

By Type

  • Point-of-care testing
  • Immunodiagnostics
  • Molecular diagnostics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rising approvals for influenza diagnostic products as one of the prime reasons driving the influenza diagnostics market growth during the next few years. Also, the surge in a number of genetic characterization studies on the influenza virus and the rising adoption of rapid diagnostic products in physician office laboratories will lead to sizable demand in the market.

The report on the influenza diagnostics market covers the following areas:

  • Influenza diagnostics market sizing
  • Influenza diagnostics market forecast
  • Influenza diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp.. Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global Influenza Diagnostics Market 2023-2027 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.3 Type Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
  • 6.4 Academic and research centers - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)
  • 6.5 Homecare - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by End-user
  • Exhibit 46: Market opportunity by End-user ($ million)
  • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 48: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
  • 7.2 Comparison by Type
  • Exhibit 50: Chart on Comparison by Type
  • Exhibit 51: Data Table on Comparison by Type
  • 7.3 Point-of-care testing - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)
  • 7.4 Immunodiagnostics - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
  • 7.5 Molecular diagnostics - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Type
  • Exhibit 64: Market opportunity by Type ($ million)
  • Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
  • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 France - Market size and forecast 2022-2027
  • Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.11 Canada - Market size and forecast 2022-2027
  • Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 115: Abbott Laboratories - Overview
  • Exhibit 116: Abbott Laboratories - Business segments
  • Exhibit 117: Abbott Laboratories - Key news
  • Exhibit 118: Abbott Laboratories - Key offerings
  • Exhibit 119: Abbott Laboratories - Segment focus
  • 12.4 Becton Dickinson and Co.
  • Exhibit 120: Becton Dickinson and Co. - Overview
  • Exhibit 121: Becton Dickinson and Co. - Business segments
  • Exhibit 122: Becton Dickinson and Co. - Key news
  • Exhibit 123: Becton Dickinson and Co. - Key offerings
  • Exhibit 124: Becton Dickinson and Co. - Segment focus
  • 12.5 BICO Group AB
  • Exhibit 125: BICO Group AB - Overview
  • Exhibit 126: BICO Group AB - Business segments
  • Exhibit 127: BICO Group AB - Key offerings
  • Exhibit 128: BICO Group AB - Segment focus
  • 12.6 Bio Rad Laboratories Inc.
  • Exhibit 129: Bio Rad Laboratories Inc. - Overview
  • Exhibit 130: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 131: Bio Rad Laboratories Inc. - Key news
  • Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 133: Bio Rad Laboratories Inc. - Segment focus
  • 12.7 Biocartis Group NV
  • Exhibit 134: Biocartis Group NV - Overview
  • Exhibit 135: Biocartis Group NV - Product / Service
  • Exhibit 136: Biocartis Group NV - Key offerings
  • 12.8 bioMerieux SA
  • Exhibit 137: bioMerieux SA - Overview
  • Exhibit 138: bioMerieux SA - Product / Service
  • Exhibit 139: bioMerieux SA - Key offerings
  • 12.9 Danaher Corp.
  • Exhibit 140: Danaher Corp. - Overview
  • Exhibit 141: Danaher Corp. - Business segments
  • Exhibit 142: Danaher Corp. - Key news
  • Exhibit 143: Danaher Corp. - Key offerings
  • Exhibit 144: Danaher Corp. - Segment focus
  • 12.10 DiaSorin SpA
  • Exhibit 145: DiaSorin SpA - Overview
  • Exhibit 146: DiaSorin SpA - Business segments
  • Exhibit 147: DiaSorin SpA - Key news
  • Exhibit 148: DiaSorin SpA - Key offerings
  • Exhibit 149: DiaSorin SpA - Segment focus
  • 12.11 F. Hoffmann La Roche Ltd.
  • Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.12 Hologic Inc.
  • Exhibit 155: Hologic Inc. - Overview
  • Exhibit 156: Hologic Inc. - Business segments
  • Exhibit 157: Hologic Inc. - Key news
  • Exhibit 158: Hologic Inc. - Key offerings
  • Exhibit 159: Hologic Inc. - Segment focus
  • 12.13 Princeton BioMeditech Corp.
  • Exhibit 160: Princeton BioMeditech Corp. - Overview
  • Exhibit 161: Princeton BioMeditech Corp. - Product / Service
  • Exhibit 162: Princeton BioMeditech Corp. - Key offerings
  • 12.14 Quidelortho Corp.
  • Exhibit 163: Quidelortho Corp. - Overview
  • Exhibit 164: Quidelortho Corp. - Product / Service
  • Exhibit 165: Quidelortho Corp. - Key offerings
  • 12.15 Sd Biosensor Inc.
  • Exhibit 166: Sd Biosensor Inc. - Overview
  • Exhibit 167: Sd Biosensor Inc. - Product / Service
  • Exhibit 168: Sd Biosensor Inc. - Key offerings
  • 12.16 Siemens Healthineers AG
  • Exhibit 169: Siemens Healthineers AG - Overview
  • Exhibit 170: Siemens Healthineers AG - Business segments
  • Exhibit 171: Siemens Healthineers AG - Key news
  • Exhibit 172: Siemens Healthineers AG - Key offerings
  • Exhibit 173: Siemens Healthineers AG - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 174: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 176: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 179: Inclusions checklist
  • Exhibit 180: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 181: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 182: Research methodology
  • Exhibit 183: Validation techniques employed for market sizing
  • Exhibit 184: Information sources
  • 13.5 List of abbreviations
  • Exhibit 185: List of abbreviations